dydrogesterone has been researched along with trelstar in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Cai, R; Gao, H; Huang, J; Kuang, Y; Lin, J; Lu, X; Wang, N; Xie, Q | 1 |
Jing, M; Lin, C; Tu, X; You, B; Zhang, R | 1 |
2 other study(ies) available for dydrogesterone and trelstar
Article | Year |
---|---|
Neonatal outcomes and congenital malformations in children born after dydrogesterone application in progestin-primed ovarian stimulation protocol for IVF: a retrospective cohort study.
Topics: Adult; Cohort Studies; Congenital Abnormalities; Dydrogesterone; Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Gonadotropins; Humans; Infant, Newborn; Ovulation Induction; Pregnancy; Pregnancy Outcome; Progestins; Retrospective Studies; Triptorelin Pamoate | 2019 |
Progestin-Primed Ovarian Stimulation Versus Mild Stimulation Protocol in Advanced Age Women With Diminished Ovarian Reserve Undergoing Their First
Topics: Adult; Chorionic Gonadotropin; Clomiphene; Cohort Studies; Dydrogesterone; Female; Fertility Agents, Female; Fertilization in Vitro; Humans; Letrozole; Live Birth; Maternal Age; Medroxyprogesterone Acetate; Menotropins; Odds Ratio; Oocyte Retrieval; Ovarian Hyperstimulation Syndrome; Ovarian Reserve; Ovulation Induction; Pregnancy; Pregnancy Rate; Progestins; Retrospective Studies; Sperm Injections, Intracytoplasmic; Triptorelin Pamoate | 2021 |